Category: New products
-

Eye Disease Gene-Therapy Biotech Adds Venture Funds
A biotechnology company designing treatments for inherited eye diseases with Crispr gene editing is raising €75 million in venture financing.
-

Cell, mRNA Therapy Biotech Raises $165M in Early Funds
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body.
-

Gut Microbes Shown to Detect Colorectal Cancer
An analysis of gut bacteria and blood samples from patients indicates changes in the microbiome can provide early warnings for colorectal cancer.
-

Trial Shows LSD Treatment Reduces Anxiety Symptoms
A clinical trial shows a medication made with lysergic acid diethylamide or LSD, given in a supervised clinical setting, helps reduce anxiety and depression symptoms.
-

Precision Meds Shown Effective in Rare Cancer
Results from a clinical trial show patients with rare bile duct tumors respond to an experimental treatment blocking a specific cancer-causing protein.
-

Industry-Univ. Team Assessing Electronic Brain Biomarkers
A developer of software analyzing brain signals for neurological disease indicators is engaging medical researchers to help assess the software in real-world settings.
-

Trial to Assess Multi-Factor Blood Test for Cancer
A clinical trial is set to begin that evaluates genomic and related data from routine blood tests to screen for cancer in real-world settings.
-

Infographic – Moon Missions Planned in Decade
The U.S. program is just one of a number of planned missions to the moon, both government- and industry-sponsored, from several countries.
-

Trial to Test Smart Watch to Guide Blood Thinners
A clinical trial is planned to test heart rhythms measured with an Apple smart watch to guide use of blood thinning medicines in people with irregular heartbeat.
-

Cannabinoid Synthesis Process Licensed to Spin-Off Company
A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process.